REVATIO Adverse Event: Upper respiratory tract infection
REVATIO Adverse Event: Upper respiratory tract infection is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVATIO; Product category: Drug; Primary reaction: Upper respiratory tract infection.
| Primary drug | REVATIO |
|---|---|
| Product category | Drug |
| Primary reaction | Upper respiratory tract infection |
| All reactions | Upper respiratory tract infection; Drug dose omission; Sinusitis; Nasopharyngitis |
| Seriousness | Not serious |
| Patient outcome | Unknown |
| Patient sex | Male |
| All drugs reported | REVATIO; TYVASO; LETAIRIS; REMODULIN |
| Reporter country | US |
| Reporter type | 5 |
| Report date | 20140313 |
| Report ID | 10006701 |
$299/mo
Try FDATracker →